Last edition
News about "active pharmaceutical ingredient (API) "
Ocuvex Resubmits CRL to FDA for PDP-716 NDA, SPARC Reveals
Sun Pharma Advanced Research Company (SPARC) announced that Ocuvex Therapeutics has resubmitted a Complete Response Letter (CRL) to the US Food and Drug Administration (FDA) for the New Drug Application (NDA) of PDP-716.
Active Pharmaceutical Ingredient (API) | 20/11/2025 | By Dineshwori | 122
Lilly to Establish USD 5 Billion API Manufacturing Facility in Virginia
The new site in Virginia marks the first of four new US manufacturing sites that Lilly plans to announce this year.
Active Pharmaceutical Ingredient (API) | 17/09/2025 | By Dineshwori | 121
Dr Reddy's UK API Facility Receives Seven FDA Observations Following Inspection
Dr Reddy’s Laboratories has announced that its Active Pharmaceutical Ingredient (API) manufacturing facility in Mirfield, West Yorkshire, United Kingdom, has come under scrutiny from the United States Food and Drug Administration (FDA).
Active Pharmaceutical Ingredient (API) | 08/09/2025 | By Darshana | 332
Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
Active Pharmaceutical Ingredient (API) | 25/08/2025 | By Dineshwori | 132
The global demand for 2-Methylpiperazine is growing significantly due to its wide applicability in pharmaceutical formulations and specialty chemical development, according to a new study by Polaris Market Research.
Active Pharmaceutical Ingredient (API) | 12/08/2025 | By Dineshwori | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy